[Kaiser Health News] Biggest Insurer Shocked With Hepatitis C Costs

By Jay Hancock

April 18, 2014

UnitedHealth Group spent $100 million on hepatitis C drugs in the first three months of the year, much more than expected, the company said Thursday. The news helped drive down the biggest insurance company’s stock and underscores the challenge for all health care payers in covering Sovaldi, an expensive new pill for hepatitis C.

[button title=”Read More” link=”http://capsules.kaiserhealthnews.org/index.php/2014/04/biggest-insurer-shocked-with-sovaldi-costs/” target=”_blank” size=”” color=”” class=””]